Brainwave Entrainment Technique in Managing Anxiety and Pain Perception in Pediatric Dental Patients.
29 mai 2026 mis à jour par: Malak Hazem, Alexandria University
Effectiveness of Brainwave Entrainment on Anxiety and Pain Perception in Pediatric Dental Patients (A Randomized Controlled Clinical Trial)
Pediatric dental anxiety and pain management present significant clinical challenges during routine treatment.
While conventional behavior management techniques exist, their inconsistent effectiveness necessitates the continuous search for alternative solutions.
Brainwave entrainment (BWE) , a novel approach using audiovisual stimuli to induce relaxing alpha waves (8-12 Hz) , shows promise in anxiety and pain management.
However, its application in pediatric dentistry remains insufficiently explored, particularly for invasive dental procedures.
Aperçu de l'étude
Statut
Pas encore de recrutement
Les conditions
Intervention / Traitement
Type d'étude
Interventionnel
Inscription (Estimé)
34
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Coordonnées de l'étude
- Nom: Malak Hazem Zaghloul, BDS
- Numéro de téléphone: +201009793275
- E-mail: m.hazem161179.na@alexu.edu.eg
Lieux d'étude
-
-
-
Alexandria, Egypte
- faculty of dentistry Alexandria university
-
Contact:
- Malak Hazem Zaghloul, BDS
- Numéro de téléphone: +201009793275
- E-mail: malakhazem1998@gmail.com
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Enfant
Accepte les volontaires sains
Non
La description
Inclusion Criteria:
Participants enrolled in the study will be selected after fulfilling the following inclusion criteria:
- Healthy six to nine years old.
- Frankl behavioural rating score 2 during preoperative assessment
- Bilateral mandibular primary molars indicated for extraction.
- Written guardian consent.
Exclusion Criteria:
Children with:
- Physical disabilities or psychiatric disorders
- Epilepsy.
- Visual or hearing disabilities
- On photophobia inducing or hearing altering medications.
- Hypersensitivity to local anesthetic drugs used.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: brainwave entrainment group
Children allocated to this group will undergo 5.5 minutes of brainwave entrainment before dental treatment.
This will be delivered through a headset and a multicolored eyeset compatible with smartphones with eyes closed.The entrainment device will be introduced to the children and the parents.
The children will be given time to accommodate with the device before starting theprocedure and will undergo an entrainment stimulation.
The frequency will be set at 10 Hz and the volume level will be set around 60dB to ensure uniformity among participants.
However patients will have the option to modify the volume settings if they encounter discomfort.
|
Children allocated ot this group will undergo 5.5 minutes of brainwave entrainment before dental treatment.
This will be delivered through a headset and a multicolored eyeset compatible with smartphones with eyes closed.The entrainment device will be introduced to the children and the parents.
The children will be given time to accommodate with the device before starting theprocedure and will undergo an entrainment stimulation.
The frequency will be set at 10 Hz and the volume level will be set around 60dB to ensure uniformity among participants.
However patients will have the option to modify the volume settings if they encounter discomfort.
|
|
Comparateur actif: Basic behavior management technique
Children allocated to this group wil be managed by the basic behavior guidance techniques (Tell-Show-Do).
|
Children allocated to this group wil be managed by the basic behavior guidance techniques (Tell-Show-Do).
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Dental anxiety assessment using Venham's Clinical Anxiety Scale
Délai: At baseline (preoperatively) - during needle penetration - during extraction - immediately after extraction (postoperatively)
|
VCAS rates the child's anxiety into 6 categories with scores ranging from 0 to 5. A score of 0 means low anxiety and a score of 5 refers to debilitating anxiety so much so that the child is out of contact with the reality of the threat and the requirement of physical restraint.
The operator will assign a score to each child based on the child's response by analvsis of the recorded videotape.
|
At baseline (preoperatively) - during needle penetration - during extraction - immediately after extraction (postoperatively)
|
|
Dental anxiety assessment using Pulse rate
Délai: At baseline (preoperatively) - during injection - during extraction - immediately after extraction (postoperatively)
|
The pulse rate will be measured using a pulse oximeter
|
At baseline (preoperatively) - during injection - during extraction - immediately after extraction (postoperatively)
|
|
Dental pain assessment using Face, Legs, Activity, Cry, Consolability Scale
Délai: During injection - During extraction
|
It evaluates 5 behavioral categories namely Face, Legs, Activity, Cry, Consolability.
Each category is scored 0-2, yielding a total pain score of 0-10 (higher = more severe pain).
The operator will assign a score to each category based on the child's response by analysis of the recorded videotape.
|
During injection - During extraction
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Dental anxiety assessment using Facial Image Scale
Délai: At baseline (preoperatively) - Immediately after extraction (postoperatively)
|
The FIS comprises one item with a response set of five faces (ranging from a very sad to a very smiley face).
Children will be asked to indicate which of the faces they feel most like at that moment, it is a 'state' measure of anxiety that provides an immediate reflection of how the child is feeling.
|
At baseline (preoperatively) - Immediately after extraction (postoperatively)
|
|
Dental pain assessment using Faces Pain Scale - Revised
Délai: Immediately after injection - Immediately after extraction
|
The Faces pain scale - Revised features 6 gender neutral faces arranged horizontally, showing increasing levels of pain from "no pain" (leftmost face, scored as 0) to "very much pain" (rightmost face, scored as 10).
Children will be asked to point to the face that best matches their pain level.
|
Immediately after injection - Immediately after extraction
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Les enquêteurs
- Directeur d'études: Abdelwahab Samaha, PHD, Alexandria University
- Chaise d'étude: Nadia Aziz Wahba, PHD, Alexandria University
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Estimé)
1 mai 2026
Achèvement primaire (Estimé)
1 août 2026
Achèvement de l'étude (Estimé)
1 octobre 2026
Dates d'inscription aux études
Première soumission
18 mai 2026
Première soumission répondant aux critères de contrôle qualité
29 mai 2026
Première publication (Réel)
1 juin 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
1 juin 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
29 mai 2026
Dernière vérification
1 mai 2026
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- 1128-08/2025
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .